Bennet, Bipartisan Group Push for Outcome-Based Arrangements with Drug Manufacturers

Paying drug manufacturers for patient outcomes could help lower the costs of prescription drugs

U.S. Senators Michael Bennet (D-CO), Mark Warner (D-VA), Bill Cassidy (R-LA), and Todd Young (R-IN) urged the Government Accountability Office (GAO) to look into private sector innovations related to outcome-based arrangements with drug manufacturers to determine how to help lower prescription drug costs for patients, providers, and payers.
U.S. Senators Michael Bennet (D-CO), Chris Coons (D-DE), Bill Cassidy (R-LA), and John Barrasso (R-WY), along with U.S. Representatives Diane Black (R-TN), Mike Thompson (D-CA), Chris Collins (R-NY), and Peter Welch (D-VT), this week reintroduced legislation to encourage Medicare beneficiaries to create electronic advance directives, legal documents that allow patients to articulate their preferences for their medical care should they suffer from a debilitating illness or condition.

Bennet, Colleagues Urge Administration to Consider Overwhelming Support for National Monuments

As Interior Department moves to final stages of review, millions of Americans have expressed support for national monuments across the country

Western U.S. Senators Michael Bennet (D-CO), Martin Heinrich (D-NM), Maria Cantwell (D-NM), Catherine Cortez Masto (D-NV), and Tom Udall (D-NM) today joined public lands advocates to encourage President Trump and Interior Secretary Ryan Zinke to listen to their constituents and keep existing national monument protections in place.